AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...

Expanded eligibility for advanced ischemic stroke therapies and the first detailed recommendations pediatric stroke care are ...

This “long overdue” update expands the pools of patients eligible for thrombolysis and thrombectomy, and tackles pediatric ...

The American Heart Association/American Stroke Association released its 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke. Stroke published the guideline on Monday.

The Zoom 4S catheter is designed to simplify stroke thrombectomy by reducing device exchanges.

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and ...

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

A high neutrophil-to-lymphocyte ratio predicts poor recovery in acute ischaemic stroke, but a higher lymphocyte-to-monocyte ...

Time is of the essence in establishing the diagnosis of stroke and determining whether the patient is a candidate for thrombolytic therapy, ideally initiated within the “golden hour” after arrival at ...

A Pivotal Step in Optimizing the ADAPT 2.0 Technique for Speed and Simplicity with a Single System Setup CAMPBELL, Calif.--(BUSINESS WIRE)--January 28, 2026-- Imperative Care, Inc. today announced the ...

Vision recovery similar at 30 days, consistent with other recent randomized studies ...

Expanded eligibility for advanced stroke therapies and new recommendations for diagnosing and treating stroke in children and adults are among the major updates in the new 2026 Guideline for the Early ...